TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals board has recommended a final dividend of ₹9 per share (180% on face value of ₹5), payable on or around June 25, 2026. Earlier, an interim dividend of ₹29 per share (580%) was paid during the last quarter, bringing total dividend for FY2026 to ₹38 per share. The company also reported strong standalone financial results with net profit of ₹2,192 crores for the year ended March 31, 2026, up 16% from ₹1,888 crores in the previous year. Revenue from operations grew to ₹10,498 crores from ₹9,485 crores. The record date for the final dividend is May 29, 2026.
The increased total dividend (₹38 vs ₹35.50 in prior year) signals strong financial performance and cash generation. The JB Pharma acquisition completed in January 2026 is expected to contribute to future earnings, but the increased debt (debt equity ratio rose to 1.68x from 0.34x) from the ₹12,539 crore acquisition warrants monitoring.